List of works - Frank Dicker

A novel hierarchical prognostic model of AML solely based on molecular mutations

scientific article published on 20 August 2012

Associations between imatinib resistance conferring mutations and Philadelphia positive clonal cytogenetic evolution in CML.

scientific article published on October 2010

Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia

scientific article published in November 2009

Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing

scientific article published on 26 February 2018

Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia ⬇️

scientific article published on February 13, 2012

Flow cytometric identification of 76 patients with biclonal disease among 5523 patients with chronic lymphocytic leukaemia (B-CLL) and its genetic characterization.

scientific article

Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemia ⬇️

scientific article published on December 5, 2011

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

scientific article

Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow ⬇️

scientific article published on April 17, 2012

Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia

scientific article published on 15 October 2015

Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis

scientific article published on 10 November 2009

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

article

Quantification of rare NPM1 mutation subtypes by digital PCR.

scientific article published on 18 July 2014

Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated cases

scientific article published on February 2014

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)

scientific article

Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters

scientific article

Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia

scientific article published on April 2007

Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases

scientific article published on 24 June 2012

List of works by Frank Dicker

A novel hierarchical prognostic model of AML solely based on molecular mutations

Associations between imatinib resistance conferring mutations and Philadelphia positive clonal cytogenetic evolution in CML.

Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia

Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing

Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia ⬇️

Flow cytometric identification of 76 patients with biclonal disease among 5523 patients with chronic lymphocytic leukaemia (B-CLL) and its genetic characterization.

Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemia ⬇️

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow ⬇️

Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia

Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

Quantification of rare NPM1 mutation subtypes by digital PCR.

Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated cases

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)

Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters

Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia

Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases

mutated AML can relapse with wild-type : persistent clonal hematopoiesis can drive relapse